发明名称 |
SUPPRESSION OF ENDOGENOUS IGFBP-2 TO INHIBIT CANCER |
摘要 |
The present invention concerns the role of IGFBP-2 in cancer. Cancers that are dependent on IGFBP-2 would benefit from therapies targeting IGFBP-2. The invention discloses methods for inhibiting IGFBP-2 dependent cancers by modulating IGFBP-2 activity. Modulation can be achieved by decreasing the amounts of IGFBP-2 protein or IGFBP-2 activity, as well as other polypeptides that interact with or modify IGFBP-2. Preferred modulators of IGFBP-2 include antibodies specific for IGFBP-2 and antisense or ribozymes specific for IGFBP-2 nucleic acid. These modulators are useful for treating cancers derived from any tissue, with cancer of the prostate being preferred. Methods of treating a subject with cancer are disclosed as well as compositions of IGFBP-2 modulators and kits containing such modulators. |
申请公布号 |
WO0069454(A8) |
申请公布日期 |
2001.04.12 |
申请号 |
WO2000US13574 |
申请日期 |
2000.05.17 |
申请人 |
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM;CHAKRABARTY, SHILA;SINGH, POMILA |
发明人 |
CHAKRABARTY, SHILA;SINGH, POMILA |
分类号 |
A61K38/00;A61K38/17;A61K38/30;A61K39/00;A61K48/00;C07K16/18;C12N15/113;(IPC1-7):A61K38/17;A61K38/18 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|